Researchers identify inflammatory biomarkers in T cells

July 30, 2018, Marshall University
The team of researchers from the Marshall University School of Pharmacy and Marshall University Joan C. Edwards School of Medicine who identified inflammatory biomarkers in T cells includes (front row, from left) Jun Fan, Ph.D.; Donald A. Primerano, Ph.D.; (back row, from left) Bryanna Roar, third-year Pharm.D. student; Jeremy McAleer, Ph.D.; James Denvir, Ph.D. Credit: Marshall University

The Marshall University School of Pharmacy, in collaboration with the Marshall University Joan C. Edwards School of Medicine Genomics Core, recently released a new study that explores human T cell function under inflammatory conditions.

The findings are published in the July 19, 2018, edition of Scientific Reports, an online journal from the publishers of Nature.

"Our of T provides many possible targets for studying how environmental products control T cell activation and pro-inflammatory functions," said Jeremy P. McAleer, Ph.D., lead author and assistant professor at the Marshall School of Pharmacy. "We were encouraged to find that one of these targets, named GPR68, regulates the ability of T cells to produce chemical messengers. This may have implications for diseases on mucosal surfaces such as the lungs and gastrointestinal tract."

The study examined T cells, which protect against bacteria, fungi and viruses on mucosal surfaces. When activated against harmless substances, T cells may provoke autoimmune diseases. Findings reveal that the set of genes expressed by T cells under pro- include several G-protein-coupled receptors (GPRs). Future studies will explore if blocking the GPR68 pathway can be a potential therapy for .

The research team included faculty from the schools as well as a third-year pharmacy student.

Explore further: Colon signaling pathway key to inflammatory bowel disease

More information: Jeremy P. McAleer et al. Cytokine Regulation in Human CD4 T Cells by the Aryl Hydrocarbon Receptor and Gq-Coupled Receptors, Scientific Reports (2018). DOI: 10.1038/s41598-018-29262-4

Related Stories

Colon signaling pathway key to inflammatory bowel disease

April 2, 2018
The intestine encounters more foreign substances and potential toxins than other parts of the body, so it is not surprising that a healthy gut is maintained by the tight control of immune responses. These protect against ...

Searching for targeted treatments for inflammatory diseases

February 6, 2018
Inflammatory diseases such as Crohn's disease and multiple sclerosis have been linked to faults in a critical immune pathway that enables inflammation to continue unchecked.

New targets revealed for the treatment of inflammatory conditions

February 15, 2018
Research by the University of Bristol has shed light on the way our clotting cells and immune cells control their interactions with each other.

Igniting the rheumatoid arthritis flame through a cellular cascade

May 30, 2018
Chronic inflammatory disorders, including autoimmune diseases such as rheumatoid arthritis, involve the action of various inflammatory molecules (cytokines) produced by cells of the immune system. One such cytokine, IL-17, ...

MicroRNA could help treat cancer and asthma

February 15, 2018
A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer, according to research published in Cell Reports.

Psoriasis treated with compound derived from immune cells

April 18, 2018
A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis.

Recommended for you

Fatty acids can slow down an overheated immune system

September 21, 2018
Sometimes, the immune system mistakenly attacks the body's healthy tissue by responding to infections that do not exist. This causes chronic inflammation and leads to diseases including lupus (SLE), and this is what happens ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Rethinking an inflammatory receptor's obesity connection

September 12, 2018
Toll-like receptor 4 (TLR4) is a protein that plays a vital role in the body's immune response by sensing the presence of infection. It has long been thought to also sense particular types of fats, which suggested a mechanism ...

Excessive airway nerves tied to more severe asthma symptoms, study finds

September 5, 2018
A new study implicates remodeling of nerves in the airways as a key contributor to heightened sensitivity and airway constriction in patients with asthma.

Genetics and pollution drive severity of asthma symptoms

August 31, 2018
Asthma patients, with a specific genetic profile, exhibit more intense symptoms following exposure to traffic pollution, according to researchers at the National Institutes of Health and collaborators. The study appeared ...

Clarifying the role of a protein released by immune 'dendritic' cells could yield better treatments

August 30, 2018
Inflammatory bowel disease (IBD), which afflicts millions of people worldwide, arises when the immune system mounts an overly aggressive response against microorganisms, dietary substances, or cells of the gut. A*STAR researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.